Eli Lilly given green light in US to treat sleep disorder with weight-loss drug

Health

Eli Lilly Given Green Light In Us To Treat Sleep Disorder With Weight-Loss Drug

By Financial Times

Print this page Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US regulators have approved Eli Lilly’s Zepbound to treat adults with both sleep apnoea and obesity, marking a victory for the drugmaker as it se ...Read more

Related Posts

Staff Roundtable: How does Texas pull off an upset victory over Ohio State in the College Football Playoff Semifinal?

Staff Roundtable: How does Texas pull off an upset victory over Ohio State in the College Football Playoff Semifinal?

Jan 09, 2025
7 Benefits of The Keto Diet

7 Benefits of The Keto Diet

Dec 30, 2020
Novo Nordisk shares plunge 19% after disappointing trial results; Lilly jumps in premarket

Novo Nordisk shares plunge 19% after disappointing trial results; Lilly jumps in premarket

Dec 20, 2024
Oleksandr Usyk beats Tyson Fury to defend heavyweight titles

Oleksandr Usyk beats Tyson Fury to defend heavyweight titles

Dec 21, 2024
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.